Experience of Intravenous Calcium Treatment and Long-Term Responses to Treatment in a Patient with Hereditary Vitamin D-Resistant Rickets Resulting from a Novel Mutation

    Elvan Bayramoğlu, Şenay Savaş Erdeve, Yufei Shi, Mahmut Keskin, Semra Çeti̇nkaya, Erdal Kurnaz, Nursel Şahin, Zehra Aycan
    Image of study
    TLDR Intravenous calcium therapy is a safe and effective treatment for a rare type of rickets.
    In a case report of a 3-year-old girl with hereditary vitamin D-resistant rickets (HVDRR) due to a novel mutation in the vitamin D receptor (VDR) gene, the patient exhibited symptoms such as short stature, genu varum deformity, waddling gait, and alopecia, along with hypocalcemia, hypophosphatemia, and hyperparathyroidism. Despite 22 months of treatment with calcitriol and high-dose oral calcium, there was no response, leading to a switch to continuous high-dose intravenous (i.v.) calcium therapy for 4 months. This treatment resulted in dramatic improvement in rickets, which did not recur for 3 years post-therapy. The study concluded that i.v. calcium therapy via a central catheter is a safe and effective treatment for HVDRR.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results